Research on soluble guanylate cyclase modulation is being explored for its potential in treating heart failure. Studies and analyses are investigating its efficacy and safety, as well as its possible applications in related conditions such as pulmonary arterial hypertension and resistant hypertension. The topic is being examined through various meta-analyses, market reports, and therapeutic strategy discussions, indicating ongoing interest in its potential as a treatment target.